ORCHESTRA BIOMED HOLDINGS INC. - ORDINARY SHARES

Orchestra BioMed to Present at Upcoming Investor Conferences

20 2 2025 07:00:00 提供 Nasdaq GlobeNewswire

Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board

18 2 2025 07:00:01 提供 Nasdaq GlobeNewswire

Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference

12 2 2025 09:43:00 提供 Nasdaq GlobeNewswire

Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors

05 2 2025 07:00:00 提供 Nasdaq GlobeNewswire

Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting

09 12 2024 06:00:00 提供 Nasdaq GlobeNewswire

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

26 11 2024 15:05:00 提供 Nasdaq GlobeNewswire

Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update

12 11 2024 15:12:39 提供 Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Jefferies London Healthcare Conference

07 11 2024 07:00:01 提供 Nasdaq GlobeNewswire

Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update

12 8 2024 15:20:20 提供 Nasdaq GlobeNewswire

Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors

30 7 2024 07:00:00 提供 Nasdaq GlobeNewswire

Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

04 6 2024 07:00:00 提供 Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Jefferies Global Healthcare Conference

22 5 2024 07:43:18 提供 Nasdaq GlobeNewswire

Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update

13 5 2024 15:58:13 提供 Nasdaq GlobeNewswire

Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents

30 4 2024 07:30:00 提供 Nasdaq GlobeNewswire

Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

30 4 2024 07:00:00 提供 Nasdaq GlobeNewswire

Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update

27 3 2024 15:17:23 提供 Nasdaq GlobeNewswire

Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors

26 3 2024 07:00:00 提供 Nasdaq GlobeNewswire

Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting

13 3 2024 07:00:00 提供 Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Upcoming Investor Conferences

07 3 2024 07:00:00 提供 Nasdaq GlobeNewswire

Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients

06 3 2024 07:37:17 提供 Nasdaq GlobeNewswire